2m 2m 2m 2m 2m 2m 2m
PROTALIX BIOTHPS (PLX)
NYSE
$2.70+$0.02 (+0.75%)
Price as of Oct 02, 2026 4:15 PM EDT- $215.9MMarket Cap
- 14.53%1-Year Change
- BiotechnologyIndustry
PROTALIX BIOTHPS (PLX)
$2.70+$0.02 (+0.75%)
PLX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.68 | ||
Change | -$0.08 (-2.90%) | ||
Open | $2.77 | ||
High | $2.77 | ||
Low | $2.60 | ||
Previous Close | $2.76 | ||
Volume | 1,588,314 | ||
30-Day Average Volume | 769,540 | ||
1-Week Change | -2.55% | ||
1-Month Change | 3.47% | ||
1-Year Change | 14.53% | ||
3-Year Change | 61.45% | ||
5-Year Change | 114.40% | ||
Fundamentals | |||
Shares Outstanding | 80.6M | ||
Total Assets | $110.3M | ||
Market Cap | $215.9M | ||
Enterprise Value | $188.5M | ||
Period: QTR TTM FY | |||
Revenue | $19.8M | ||
Net Income | $3.8M | ||
Free Cash Flow | -$11.0M | ||
EBIT | $4.9M | ||
EBITDA | $5.3M | ||
Net Working Capital | $60.8M | ||
EPS | $0.05 | ||
Enterprise Value/EBITDA | 36 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 3 | ||
P/E | 54 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 12/20/2019 | ||
Earnings & Revenue